Loading…

Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death

The reaction of the Ru(PPh3)3Cl2 with HL1−3−OH (−OH stands for the oxime hydroxyl group; HL1−OH=diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2−OH=diacetylmonoxime‐S‐(4‐methyl)benzyldithiocarbazonate; and HL3−OH=diacetylmonoxime‐S‐(4‐chloro)benzyl‐dithiocarbazonate) gives three new ruthenium complex...

Full description

Saved in:
Bibliographic Details
Published in:Chemistry : a European journal 2023-03, Vol.29 (18), p.e202202694-n/a
Main Authors: Sahu, Gurunath, Patra, Sushree Aradhana, Lima, Sudhir, Das, Sanchita, Görls, Helmar, Plass, Winfried, Dinda, Rupam
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4134-754207b9b30657ccb9335e249979e0a79c8627df70ef22fc1ff2f82255d1ad3e3
cites cdi_FETCH-LOGICAL-c4134-754207b9b30657ccb9335e249979e0a79c8627df70ef22fc1ff2f82255d1ad3e3
container_end_page n/a
container_issue 18
container_start_page e202202694
container_title Chemistry : a European journal
container_volume 29
creator Sahu, Gurunath
Patra, Sushree Aradhana
Lima, Sudhir
Das, Sanchita
Görls, Helmar
Plass, Winfried
Dinda, Rupam
description The reaction of the Ru(PPh3)3Cl2 with HL1−3−OH (−OH stands for the oxime hydroxyl group; HL1−OH=diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2−OH=diacetylmonoxime‐S‐(4‐methyl)benzyldithiocarbazonate; and HL3−OH=diacetylmonoxime‐S‐(4‐chloro)benzyl‐dithiocarbazonate) gives three new ruthenium complexes [RuII(L1−3−H)(PPh3)2Cl] (1–3) (−H stands for imine hydrogen) coordinated with dithiocarbazate imine as the final products. All ruthenium(II) complexes (1–3) have been characterized by elemental (CHNS) analyses, IR, UV‐vis, NMR (1H, 13C, and 31P) spectroscopy, HR‐ESI‐MS spectrometry and also, the structure of 1–2 was further confirmed by single crystal X‐ray crystallography. The solution/aqueous stability, hydrophobicity, DNA interactions, and cell viability studies of 1–3 against HeLa, HT‐29, and NIH‐3T3 cell lines were performed. Cell viability results suggested 3 being the most cytotoxic of the series with IC50 6.9±0.2 μM against HeLa cells. Further, an apoptotic mechanism of cell death was confirmed by cell cycle analysis and Annexin V‐FITC/PI double staining techniques. In this regard, the live cell confocal microscopy results revealed that compounds primarily target the mitochondria against HeLa, and HT‐29 cell lines. Moreover, these ruthenium complexes elevate the ROS level by inducing mitochondria targeting apoptotic cell death. Synthesis, characterization, ruthenium‐assisted oxime to imine transformation, solution/aqueous phase stability, hydrophobicity, DNA interaction, and cytotoxicity studies (cellular localization, and apoptosis) of three new ruthenium(II)‐dithiocarbazate complexes are documented. This report reveals the detailed study of Ru(II) complexes as effective anticancer agents by inducing a mitochondrial‐targeted apoptotic mode of cell death in human cancer cells.
doi_str_mv 10.1002/chem.202202694
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2760820707</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2791892299</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4134-754207b9b30657ccb9335e249979e0a79c8627df70ef22fc1ff2f82255d1ad3e3</originalsourceid><addsrcrecordid>eNqFkc9rFDEUx4Modq1ePUrAS4XOmh8zycTbuq12oUWw9TxkMm86KTPJmmSU9eTFu3-jf4kpWyt4ER68y-f7eQ--CD2nZEkJYa_NANOSEZZHqPIBWtCK0YJLUT1EC6JKWYiKqwP0JMYbQogSnD9GB1xUqqaCLNCPj3MawNl5OtpsXv36_vPEpsF6o0Orv-kEEeuIVy5Zo52BgFfX4FJ8gy93Lueijcf40o9zst7htzDoL9aHY6xdhy9s8mbwrgtWZ--VDteQoMOrrd8mn4V4DeOIT0Cn4Sl61OsxwrO7fYg-vTu9Wp8V5x_eb9ar88KUlJeFrEpGZKtaTkQljWkV5xWwUimpgGipTC2Y7HpJoGesN7TvWV8zVlUd1R0HfoiO9t5t8J9niKmZbDT5De3Az7FhUpA6nyAyoy__QW_8HFz-LlOK1ooxpTK13FMm-BgD9M022EmHXUNJc1tQc1tQc19QDry4087tBN09_qeRDKg98NWOsPuPrlmfnV78lf8GzuGfAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791892299</pqid></control><display><type>article</type><title>Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Sahu, Gurunath ; Patra, Sushree Aradhana ; Lima, Sudhir ; Das, Sanchita ; Görls, Helmar ; Plass, Winfried ; Dinda, Rupam</creator><creatorcontrib>Sahu, Gurunath ; Patra, Sushree Aradhana ; Lima, Sudhir ; Das, Sanchita ; Görls, Helmar ; Plass, Winfried ; Dinda, Rupam</creatorcontrib><description>The reaction of the Ru(PPh3)3Cl2 with HL1−3−OH (−OH stands for the oxime hydroxyl group; HL1−OH=diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2−OH=diacetylmonoxime‐S‐(4‐methyl)benzyldithiocarbazonate; and HL3−OH=diacetylmonoxime‐S‐(4‐chloro)benzyl‐dithiocarbazonate) gives three new ruthenium complexes [RuII(L1−3−H)(PPh3)2Cl] (1–3) (−H stands for imine hydrogen) coordinated with dithiocarbazate imine as the final products. All ruthenium(II) complexes (1–3) have been characterized by elemental (CHNS) analyses, IR, UV‐vis, NMR (1H, 13C, and 31P) spectroscopy, HR‐ESI‐MS spectrometry and also, the structure of 1–2 was further confirmed by single crystal X‐ray crystallography. The solution/aqueous stability, hydrophobicity, DNA interactions, and cell viability studies of 1–3 against HeLa, HT‐29, and NIH‐3T3 cell lines were performed. Cell viability results suggested 3 being the most cytotoxic of the series with IC50 6.9±0.2 μM against HeLa cells. Further, an apoptotic mechanism of cell death was confirmed by cell cycle analysis and Annexin V‐FITC/PI double staining techniques. In this regard, the live cell confocal microscopy results revealed that compounds primarily target the mitochondria against HeLa, and HT‐29 cell lines. Moreover, these ruthenium complexes elevate the ROS level by inducing mitochondria targeting apoptotic cell death. Synthesis, characterization, ruthenium‐assisted oxime to imine transformation, solution/aqueous phase stability, hydrophobicity, DNA interaction, and cytotoxicity studies (cellular localization, and apoptosis) of three new ruthenium(II)‐dithiocarbazate complexes are documented. This report reveals the detailed study of Ru(II) complexes as effective anticancer agents by inducing a mitochondrial‐targeted apoptotic mode of cell death in human cancer cells.</description><identifier>ISSN: 0947-6539</identifier><identifier>EISSN: 1521-3765</identifier><identifier>DOI: 10.1002/chem.202202694</identifier><identifier>PMID: 36598160</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Annexin V ; Anticancer properties ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Antitumor agents ; Apoptosis ; Cell cycle ; Cell death ; Cell Line, Tumor ; Cell lines ; Cell viability ; Chemistry ; Confocal microscopy ; Coordination Complexes - chemistry ; Coordination Complexes - pharmacology ; Crystallography ; Cytotoxicity ; Deoxyribonucleic acid ; DNA ; DNA interaction ; HeLa Cells ; Humans ; Hydrophobicity ; Hydroxyl groups ; Imines ; Mitochondria ; mitochondria-mediated apoptosis ; Mortality ; NMR ; Nuclear magnetic resonance ; Ruthenium ; Ruthenium - chemistry ; Ruthenium compounds ; ruthenium(II)-dithiocarbazates ; Single crystals ; solution study ; Spectrometry ; Spectroscopy</subject><ispartof>Chemistry : a European journal, 2023-03, Vol.29 (18), p.e202202694-n/a</ispartof><rights>2023 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH</rights><rights>2023 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4134-754207b9b30657ccb9335e249979e0a79c8627df70ef22fc1ff2f82255d1ad3e3</citedby><cites>FETCH-LOGICAL-c4134-754207b9b30657ccb9335e249979e0a79c8627df70ef22fc1ff2f82255d1ad3e3</cites><orcidid>0000-0001-9452-7791</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36598160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sahu, Gurunath</creatorcontrib><creatorcontrib>Patra, Sushree Aradhana</creatorcontrib><creatorcontrib>Lima, Sudhir</creatorcontrib><creatorcontrib>Das, Sanchita</creatorcontrib><creatorcontrib>Görls, Helmar</creatorcontrib><creatorcontrib>Plass, Winfried</creatorcontrib><creatorcontrib>Dinda, Rupam</creatorcontrib><title>Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death</title><title>Chemistry : a European journal</title><addtitle>Chemistry</addtitle><description>The reaction of the Ru(PPh3)3Cl2 with HL1−3−OH (−OH stands for the oxime hydroxyl group; HL1−OH=diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2−OH=diacetylmonoxime‐S‐(4‐methyl)benzyldithiocarbazonate; and HL3−OH=diacetylmonoxime‐S‐(4‐chloro)benzyl‐dithiocarbazonate) gives three new ruthenium complexes [RuII(L1−3−H)(PPh3)2Cl] (1–3) (−H stands for imine hydrogen) coordinated with dithiocarbazate imine as the final products. All ruthenium(II) complexes (1–3) have been characterized by elemental (CHNS) analyses, IR, UV‐vis, NMR (1H, 13C, and 31P) spectroscopy, HR‐ESI‐MS spectrometry and also, the structure of 1–2 was further confirmed by single crystal X‐ray crystallography. The solution/aqueous stability, hydrophobicity, DNA interactions, and cell viability studies of 1–3 against HeLa, HT‐29, and NIH‐3T3 cell lines were performed. Cell viability results suggested 3 being the most cytotoxic of the series with IC50 6.9±0.2 μM against HeLa cells. Further, an apoptotic mechanism of cell death was confirmed by cell cycle analysis and Annexin V‐FITC/PI double staining techniques. In this regard, the live cell confocal microscopy results revealed that compounds primarily target the mitochondria against HeLa, and HT‐29 cell lines. Moreover, these ruthenium complexes elevate the ROS level by inducing mitochondria targeting apoptotic cell death. Synthesis, characterization, ruthenium‐assisted oxime to imine transformation, solution/aqueous phase stability, hydrophobicity, DNA interaction, and cytotoxicity studies (cellular localization, and apoptosis) of three new ruthenium(II)‐dithiocarbazate complexes are documented. This report reveals the detailed study of Ru(II) complexes as effective anticancer agents by inducing a mitochondrial‐targeted apoptotic mode of cell death in human cancer cells.</description><subject>Annexin V</subject><subject>Anticancer properties</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antitumor agents</subject><subject>Apoptosis</subject><subject>Cell cycle</subject><subject>Cell death</subject><subject>Cell Line, Tumor</subject><subject>Cell lines</subject><subject>Cell viability</subject><subject>Chemistry</subject><subject>Confocal microscopy</subject><subject>Coordination Complexes - chemistry</subject><subject>Coordination Complexes - pharmacology</subject><subject>Crystallography</subject><subject>Cytotoxicity</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA interaction</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Hydrophobicity</subject><subject>Hydroxyl groups</subject><subject>Imines</subject><subject>Mitochondria</subject><subject>mitochondria-mediated apoptosis</subject><subject>Mortality</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Ruthenium</subject><subject>Ruthenium - chemistry</subject><subject>Ruthenium compounds</subject><subject>ruthenium(II)-dithiocarbazates</subject><subject>Single crystals</subject><subject>solution study</subject><subject>Spectrometry</subject><subject>Spectroscopy</subject><issn>0947-6539</issn><issn>1521-3765</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNqFkc9rFDEUx4Modq1ePUrAS4XOmh8zycTbuq12oUWw9TxkMm86KTPJmmSU9eTFu3-jf4kpWyt4ER68y-f7eQ--CD2nZEkJYa_NANOSEZZHqPIBWtCK0YJLUT1EC6JKWYiKqwP0JMYbQogSnD9GB1xUqqaCLNCPj3MawNl5OtpsXv36_vPEpsF6o0Orv-kEEeuIVy5Zo52BgFfX4FJ8gy93Lueijcf40o9zst7htzDoL9aHY6xdhy9s8mbwrgtWZ--VDteQoMOrrd8mn4V4DeOIT0Cn4Sl61OsxwrO7fYg-vTu9Wp8V5x_eb9ar88KUlJeFrEpGZKtaTkQljWkV5xWwUimpgGipTC2Y7HpJoGesN7TvWV8zVlUd1R0HfoiO9t5t8J9niKmZbDT5De3Az7FhUpA6nyAyoy__QW_8HFz-LlOK1ooxpTK13FMm-BgD9M022EmHXUNJc1tQc1tQc19QDry4087tBN09_qeRDKg98NWOsPuPrlmfnV78lf8GzuGfAg</recordid><startdate>20230328</startdate><enddate>20230328</enddate><creator>Sahu, Gurunath</creator><creator>Patra, Sushree Aradhana</creator><creator>Lima, Sudhir</creator><creator>Das, Sanchita</creator><creator>Görls, Helmar</creator><creator>Plass, Winfried</creator><creator>Dinda, Rupam</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9452-7791</orcidid></search><sort><creationdate>20230328</creationdate><title>Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death</title><author>Sahu, Gurunath ; Patra, Sushree Aradhana ; Lima, Sudhir ; Das, Sanchita ; Görls, Helmar ; Plass, Winfried ; Dinda, Rupam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4134-754207b9b30657ccb9335e249979e0a79c8627df70ef22fc1ff2f82255d1ad3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Annexin V</topic><topic>Anticancer properties</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antitumor agents</topic><topic>Apoptosis</topic><topic>Cell cycle</topic><topic>Cell death</topic><topic>Cell Line, Tumor</topic><topic>Cell lines</topic><topic>Cell viability</topic><topic>Chemistry</topic><topic>Confocal microscopy</topic><topic>Coordination Complexes - chemistry</topic><topic>Coordination Complexes - pharmacology</topic><topic>Crystallography</topic><topic>Cytotoxicity</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA interaction</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Hydrophobicity</topic><topic>Hydroxyl groups</topic><topic>Imines</topic><topic>Mitochondria</topic><topic>mitochondria-mediated apoptosis</topic><topic>Mortality</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Ruthenium</topic><topic>Ruthenium - chemistry</topic><topic>Ruthenium compounds</topic><topic>ruthenium(II)-dithiocarbazates</topic><topic>Single crystals</topic><topic>solution study</topic><topic>Spectrometry</topic><topic>Spectroscopy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sahu, Gurunath</creatorcontrib><creatorcontrib>Patra, Sushree Aradhana</creatorcontrib><creatorcontrib>Lima, Sudhir</creatorcontrib><creatorcontrib>Das, Sanchita</creatorcontrib><creatorcontrib>Görls, Helmar</creatorcontrib><creatorcontrib>Plass, Winfried</creatorcontrib><creatorcontrib>Dinda, Rupam</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Chemistry : a European journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sahu, Gurunath</au><au>Patra, Sushree Aradhana</au><au>Lima, Sudhir</au><au>Das, Sanchita</au><au>Görls, Helmar</au><au>Plass, Winfried</au><au>Dinda, Rupam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death</atitle><jtitle>Chemistry : a European journal</jtitle><addtitle>Chemistry</addtitle><date>2023-03-28</date><risdate>2023</risdate><volume>29</volume><issue>18</issue><spage>e202202694</spage><epage>n/a</epage><pages>e202202694-n/a</pages><issn>0947-6539</issn><eissn>1521-3765</eissn><abstract>The reaction of the Ru(PPh3)3Cl2 with HL1−3−OH (−OH stands for the oxime hydroxyl group; HL1−OH=diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2−OH=diacetylmonoxime‐S‐(4‐methyl)benzyldithiocarbazonate; and HL3−OH=diacetylmonoxime‐S‐(4‐chloro)benzyl‐dithiocarbazonate) gives three new ruthenium complexes [RuII(L1−3−H)(PPh3)2Cl] (1–3) (−H stands for imine hydrogen) coordinated with dithiocarbazate imine as the final products. All ruthenium(II) complexes (1–3) have been characterized by elemental (CHNS) analyses, IR, UV‐vis, NMR (1H, 13C, and 31P) spectroscopy, HR‐ESI‐MS spectrometry and also, the structure of 1–2 was further confirmed by single crystal X‐ray crystallography. The solution/aqueous stability, hydrophobicity, DNA interactions, and cell viability studies of 1–3 against HeLa, HT‐29, and NIH‐3T3 cell lines were performed. Cell viability results suggested 3 being the most cytotoxic of the series with IC50 6.9±0.2 μM against HeLa cells. Further, an apoptotic mechanism of cell death was confirmed by cell cycle analysis and Annexin V‐FITC/PI double staining techniques. In this regard, the live cell confocal microscopy results revealed that compounds primarily target the mitochondria against HeLa, and HT‐29 cell lines. Moreover, these ruthenium complexes elevate the ROS level by inducing mitochondria targeting apoptotic cell death. Synthesis, characterization, ruthenium‐assisted oxime to imine transformation, solution/aqueous phase stability, hydrophobicity, DNA interaction, and cytotoxicity studies (cellular localization, and apoptosis) of three new ruthenium(II)‐dithiocarbazate complexes are documented. This report reveals the detailed study of Ru(II) complexes as effective anticancer agents by inducing a mitochondrial‐targeted apoptotic mode of cell death in human cancer cells.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36598160</pmid><doi>10.1002/chem.202202694</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-9452-7791</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0947-6539
ispartof Chemistry : a European journal, 2023-03, Vol.29 (18), p.e202202694-n/a
issn 0947-6539
1521-3765
language eng
recordid cdi_proquest_miscellaneous_2760820707
source Wiley-Blackwell Read & Publish Collection
subjects Annexin V
Anticancer properties
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Antitumor agents
Apoptosis
Cell cycle
Cell death
Cell Line, Tumor
Cell lines
Cell viability
Chemistry
Confocal microscopy
Coordination Complexes - chemistry
Coordination Complexes - pharmacology
Crystallography
Cytotoxicity
Deoxyribonucleic acid
DNA
DNA interaction
HeLa Cells
Humans
Hydrophobicity
Hydroxyl groups
Imines
Mitochondria
mitochondria-mediated apoptosis
Mortality
NMR
Nuclear magnetic resonance
Ruthenium
Ruthenium - chemistry
Ruthenium compounds
ruthenium(II)-dithiocarbazates
Single crystals
solution study
Spectrometry
Spectroscopy
title Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T09%3A26%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ruthenium(II)%E2%80%90Dithiocarbazates%20as%20Anticancer%20Agents:%20Synthesis,%20Solution%20Behavior,%20and%20Mitochondria%E2%80%90Targeted%20Apoptotic%20Cell%20Death&rft.jtitle=Chemistry%20:%20a%20European%20journal&rft.au=Sahu,%20Gurunath&rft.date=2023-03-28&rft.volume=29&rft.issue=18&rft.spage=e202202694&rft.epage=n/a&rft.pages=e202202694-n/a&rft.issn=0947-6539&rft.eissn=1521-3765&rft_id=info:doi/10.1002/chem.202202694&rft_dat=%3Cproquest_cross%3E2791892299%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4134-754207b9b30657ccb9335e249979e0a79c8627df70ef22fc1ff2f82255d1ad3e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2791892299&rft_id=info:pmid/36598160&rfr_iscdi=true